News

Filter

Current filters:

None

37 to 46 of 96663 results

Novartis’ strong third-qtr boosted by sale of Idenix stake

Novartis’ strong third-qtr boosted by sale of Idenix stake

28-10-2014

Swiss pharma major Novartis this morning reported that sales for the third quarter of 2014 rose 4% to…

AlconFinancialNovartisPharmaceuticalSandozSwitzerland

Sanofi's third quarter figures are on track but shares fall on diabetes price competition warning

Sanofi's third quarter figures are on track but shares fall on diabetes price competition warning

28-10-2014

French drug major Sanofi’s third-quarter earnings are in focus, but the company’s shares have plummeted…

FinancialFranceGenzymePharmaceuticalSanofi

Zogenix acquires UK-based Brabant Pharma for up to $130 million

28-10-2014

US CNS focused drugmaker Zogenix says it has acquired Brabant Pharma, a privately-held UK-based pharmaceutical…

BrabafenBrabant PharmaMergers & AcquisitionsNeurologicalPharmaceuticalZogenix

Favorable court ruling for TMC’s Angiomax patent litigation

28-10-2014

US drugmaker The Medicines Company says that the US District Court for the Northern District of Illinois…

AngiomaxCardio-vascularGenericsMylanThe Medicines CompanyUSA

Licensing deal index shows re-emergence of late-stage deals

Licensing deal index shows re-emergence of late-stage deals

28-10-2014

Licensing deals among biotech companies have recently shown a healthy surge, especially in later stages.

BiotechnologyCelgene Corp.FinancialLicensingMorrisonUK

Takeda and Lilly’s fine is reduced in Actos case

Takeda and Lilly’s fine is reduced in Actos case

28-10-2014

A US district court has reduced the damages to be paid by Japan’s largest drugmaker Takeda Pharmaceutical…

ActosDiabetesEli LillyLegalPharmaceuticalTakeda PharmaceuticalUSA

UPDATED: Sanofi chief executive Viehbacher allegedly issues letter to company board defending his position

UPDATED: Sanofi chief executive Viehbacher allegedly issues letter to company board defending his position

28-10-2014

Chris Viehbacher, chief executive of French drug major Sanofi, has urged the company’s board to clarify…

BoardroomFranceLantusPharmaceuticalSanofi

Despite restructuring costs, Amgen’s third-qtr beats expectations

Despite restructuring costs, Amgen’s third-qtr beats expectations

28-10-2014

US biotech major Amgen posted a fall in earnings for the third-quarter of 2014, due to restructuring,…

AmgenBiotechnologyFinancialThousand Oaks, CaliforniaUSA

37 to 46 of 96663 results

Parexel

Parexel

Back to top